Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised Nalka Strukturfond AB in connection with the acquisition of Cibes
Mandate

Vinge advised Nalka Strukturfond AB in connection with the acquisition of Cibes

June 13, 2017 Banking and Finance

Vinge has advised Nalka Strukturfond AB in connection with the acquisition of CL Intressenter AB (”Cibes”) from R12 Kapital Fund I AB as well as a number of minority owners.

Cibes is a leading manufacturer of platform lifts with its base in Gävle and with global operations. The transaction is conditional upon approval by the relevant competition authorities.

Vinge’s team consisted of responsible partner Jonas Johansson and partner Peter Sundgren together with, among others, associates Johan Mattsson, Peter Issa, Andrea Ahlgren, Lova Unge, Jasmin Draszka Ali, Frida Ställborn, Ilze Lukins, Lionardo Ojeda, Fredrika Hjelmberg, Martin Boström, Grant McKelvey and Xandra Ståhlberg as well as senior counsel Qun Gu and VDR specialist Anna Hellohf. Partner Louise Brorsson Salomon together with associate Helena Håkansson provided acquisition financing advice.

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025